J. Casper

1.5k total citations
41 papers, 970 citations indexed

About

J. Casper is a scholar working on Hematology, Surgery and Molecular Biology. According to data from OpenAlex, J. Casper has authored 41 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 14 papers in Surgery and 14 papers in Molecular Biology. Recurrent topics in J. Casper's work include Testicular diseases and treatments (14 papers), Hematopoietic Stem Cell Transplantation (13 papers) and Cancer therapeutics and mechanisms (7 papers). J. Casper is often cited by papers focused on Testicular diseases and treatments (14 papers), Hematopoietic Stem Cell Transplantation (13 papers) and Cancer therapeutics and mechanisms (7 papers). J. Casper collaborates with scholars based in Germany, United States and Finland. J. Casper's co-authors include Hans‐Joachim Schmoll, Carsten Bokemeyer, Mathias Freund, A. Harstrick, Theresa Dunn, Lothar Kanz, J. Beyer, A. Gerl, Daniel Wolff and Viktor Grünwald and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

J. Casper

41 papers receiving 950 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Casper Germany 17 395 374 258 221 179 41 970
J. L. Pico France 14 306 0.8× 282 0.8× 231 0.9× 211 1.0× 148 0.8× 23 894
Francesc Cobo Spain 18 352 0.9× 99 0.3× 266 1.0× 367 1.7× 176 1.0× 38 1.2k
Gerald L. Messerschmidt United States 12 123 0.3× 111 0.3× 115 0.4× 175 0.8× 166 0.9× 26 559
Patrizia Lista Italy 12 325 0.8× 69 0.2× 181 0.7× 173 0.8× 252 1.4× 34 735
Luigi Salvagno Italy 15 121 0.3× 98 0.3× 115 0.4× 270 1.2× 55 0.3× 46 618
Jens Ersbøll Denmark 15 371 0.9× 76 0.2× 276 1.1× 381 1.7× 64 0.4× 29 1.1k
Tim Svenstrup Poulsen Denmark 17 173 0.4× 66 0.2× 324 1.3× 323 1.5× 77 0.4× 71 896
A. M. Gianni Italy 15 160 0.4× 78 0.2× 109 0.4× 294 1.3× 63 0.4× 26 619
Roland Sonntag Switzerland 20 57 0.1× 732 2.0× 485 1.9× 471 2.1× 62 0.3× 48 1.5k
Donna Stock-Novack United States 10 246 0.6× 154 0.4× 181 0.7× 249 1.1× 67 0.4× 11 673

Countries citing papers authored by J. Casper

Since Specialization
Citations

This map shows the geographic impact of J. Casper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Casper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Casper more than expected).

Fields of papers citing papers by J. Casper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Casper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Casper. The network helps show where J. Casper may publish in the future.

Co-authorship network of co-authors of J. Casper

This figure shows the co-authorship network connecting the top 25 collaborators of J. Casper. A scholar is included among the top collaborators of J. Casper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Casper. J. Casper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Metzner, Bernd, Christiane Pott, Thomas Müller, et al.. (2013). Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation. Annals of Oncology. 24(6). 1609–1615. 16 indexed citations
2.
Koenigsmann, Michael, J. Casper, Christoph Kahl, et al.. (2013). Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial. Bone Marrow Transplantation. 49(3). 410–415. 7 indexed citations
3.
Kahl, Christoph, Herbert G. Sayer, Axel Hinke, Mathias Freund, & J. Casper. (2011). Early versus late administration of pegfilgrastim after high-dose chemotherapy and autologous hematopoietic stem cell transplantation. Journal of Cancer Research and Clinical Oncology. 138(3). 513–517. 2 indexed citations
4.
Casper, J., et al.. (2009). Erdheim-Chester-Erkrankung der Orbita mit Kompressionsneuropathie. Der Ophthalmologe. 107(3). 266–269. 4 indexed citations
5.
Wolff, Daniel, Stefan Wilhelm, J. Hahn, et al.. (2006). Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease. Bone Marrow Transplantation. 38(6). 445–451. 42 indexed citations
6.
Casper, J., Stefan Wilhelm, Beate Steiner, et al.. (2005). Allogene Blutstammzelltransplantation von Risikopatienten nach Konditionierung mit Treosulfan und Fludarabin. DMW - Deutsche Medizinische Wochenschrift. 130(38). 2125–2129. 2 indexed citations
7.
Koenigsmann, Michael, Martin Mohren, Kathleen Jentsch‐Ullrich, et al.. (2004). High-dose treosulfan in patients with relapsed or refractory high-grade lymphoma receiving tandem autologous blood stem cell transplantation. Bone Marrow Transplantation. 34(6). 477–483. 18 indexed citations
8.
9.
Wolff, Daniel, Beate Steiner, S. Stilgenbauer, et al.. (2004). Treatment with campath‐1H for relapsed chronic lymphocytic leukemia after allogeneic peripheral blood stem cell transplantation does not abrogate the development of chronic GVHD. European Journal Of Haematology. 72(2). 145–148. 5 indexed citations
10.
Casper, J. & Marcel Freund. (2004). Treosulfan based conditioning for autologous and allogeneic hematopoietic stem cell transplantation. International Journal of Clinical Pharmacology and Therapeutics. 42(11). 661–662. 2 indexed citations
11.
Kollmannsberger, Christian, N. Schleucher, Oliver Rick, et al.. (2003). Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support. European Journal of Cancer. 39(6). 775–782. 4 indexed citations
12.
Kahl, Christoph, Daniel Wolff, Beate Steiner, et al.. (2002). Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation. Annals of Hematology. 81(11). 646–650. 26 indexed citations
13.
Malek, Nisar P., J. Casper, Leendert H. J. Looijenga, et al.. (1997). Quantification of additional short arms of chromosome 12 in germ cell tumours using the polymerase chain reaction. European Journal of Cancer. 33(9). 1488–1494. 10 indexed citations
14.
Dunn, Theresa, et al.. (1997). Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines. Investigational New Drugs. 15(2). 109–114. 74 indexed citations
15.
Bokemeyer, Carsten, Hans‐Joachim Schmoll, E. Ludwig, et al.. (1994). The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines remains unaltered by the uroprotector mesna. British Journal of Cancer. 69(5). 863–867. 8 indexed citations
16.
Harstrick, A., Hans‐Joachim Schmoll, Hans‐Joachim Wilke, et al.. (1991). Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.. Journal of Clinical Oncology. 9(9). 1549–1555. 74 indexed citations
17.
Tesch, Hans, J. Casper, J Lyons, et al.. (1990). Cellular oncogenes in human teratocarcinoma cell lines. International Journal of Andrology. 13(5). 377–388. 12 indexed citations
18.
Harstrick, A., et al.. (1990). Comparative activity of four anthracyclines against heterotransplanted germ cell tumor lines. Investigational New Drugs. 8(S1). S19–S24. 7 indexed citations
19.
20.
Gabius, Hans‐Joachim, Reinhild Engelhardt, J. Casper, et al.. (1985). Cell surface lectins of transplantable human teratocarcinoma cells: purification of a new mannan-specific endogenous lectin.. PubMed. 6(2). 145–56. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. L. Pico Breakdown of academic impact, for papers by Francesc Cobo Breakdown of academic impact, for papers by Gerald L. Messerschmidt Breakdown of academic impact, for papers by Patrizia Lista Breakdown of academic impact, for papers by Luigi Salvagno Breakdown of academic impact, for papers by Jens Ersbøll Breakdown of academic impact, for papers by Tim Svenstrup Poulsen Breakdown of academic impact, for papers by A. M. Gianni Breakdown of academic impact, for papers by Roland Sonntag Breakdown of academic impact, for papers by Donna Stock-Novack
Rankless by CCL
2026